Nitric oxide nanosensor offers autism diagnostic hope
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Oct-2026 06:16 ET (26-Oct-2026 10:16 GMT/UTC)
A nanosensor measured nitric oxide from patient-derived stem cells. Autism patients produced ~6nM, intellectual disability patients ~11nM, and healthy individuals ~65nM, despite sharing the same genetic mutation. This differential production suggests nitric oxide levels can distinguish autism from other neurodevelopmental disorders with overlapping causes, offering a potential biomarker for more precise diagnosis.
Anglia Ruskin University (ARU) has secured £4.8 million from NHS England to continue delivering the NHS Clinical Entrepreneur Programme (CEP), which helps National Health Service staff develop innovations alongside their day jobs.
Since launching with ARU in 2016, CEP has supported the creation of 691 businesses that address real-world healthcare challenges and helped raise more than £1.27 billion of investment.